Roaccutane for Acne Treatment
Acne (or acne vulgaris) is a widespread condition, according to statistics every 8 out of 10 people aged 12-24 suffer from acne breakouts. Roaccutane is one of the most effective systemic medications used for the treatment of severe forms of acne irrespective of their causes. This preparation is administered only when other medications and traditional or alternative methods aimed at the treatment of pimples cannot help with this condition. More information about medications for the treatment of this disease can be found on http://www.drugs-med.com.
The active component of Roaccutane is isotretinoin, a retinoid and a structural analog of vitamin A. Isotretinoin affects all major stages of acne development which results in maximum therapeutic effect in the treatment of this condition. In the human body, this medication affects the function of the sebaceous glands (reduces the secretion of the sebum and the size of the glands), influences the processes of the skin cell and hair follicle maturation (reduces hyperkeratinization, normalizes the processes of skin cell maturation and division) and shows pronounced anti-inflammatory, antibacterial and anti-androgenic effects.
Acne treatment that involves isotretinoin should be strictly controlled by a doctor. Usually, the course of treatment lasts from 3 to 5 months depending on the severity of the condition. It’s important to understand that the treatment with Roaccutane can lead to clinical recovery or prolonged remission of the condition provided that all the doctor’s recommendations concerning the daily dosage and duration of the treatment are strictly followed.
The treatment of acne with Roaccutane often provokes the following adverse reactions (especially in the first months of the treatment):
Dryness of the skin, lips, eyes, mouth, throat, nose;
Back pain, headache, muscle and joint pains;
Changes in blood tests;
High sensitivity to sunlight which causes sunburns;
Blood in the urine.
All patients undergoing Roaccutane therapy should limit the use of alcohol and reduce the consumption of very fatty foods as well as fast food for the whole period of treatment. Isotretinoin is a teratogenic substance, which means it has a high risk of causing permanent fetal damage, and therefore, it cannot and should not be used in pregnant women and in those who are planning to get pregnant. That’s why female patients are recommended to use dual contraceptive method during the entire period of treatment and one month after the end of Roaccutane therapy.